| 3. | New Nomenclature for Chromatin-Modifying Enzymes Pages 633-636 C. David Allis, Shelley L. Berger, Jacques Cote, Sharon Dent, Thomas Jenuwien, Tony Kouzarides, Lorraine Pillus, Danny Reinberg, Yang Shi, Ramin Shiekhattar, Ali Shilatifard, Jerry Workman and Yi Zhang | | | 13. | IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis Pages 669-681 Eugene Varfolomeev, John W. Blankenship, Sarah M. Wayson, Anna V. Fedorova, Nobuhiko Kayagaki, Parie Garg, Kerry Zobel, Jasmin N. Dynek, Linda O. Elliott, Heidi J.A. Wallweber, John A. Flygare, Wayne J. Fairbrother, Kurt Deshayes, Vishva M. Dixit and Domagoj Vucic | | | 14. | IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis Pages 682-693 James E. Vince, W. Wei-Lynn Wong, Nufail Khan, Rebecca Feltham, Diep Chau, Afsar U. Ahmed, Christopher A. Benetatos, Srinivas K. Chunduru, Stephen M. Condon, Mark McKinlay, Robert Brink, Martin Leverkus, Vinay Tergaonkar, Pascal Schneider, Bernard A. Callus, Frank Koentgen, David L. Vaux and John Silke | | | 22. | Skeletal Muscle Performance Determined by Modulation of Number of Myosin Motors Rather Than Motor Force or Stroke Size Pages 784-795 Gabriella Piazzesi, Massimo Reconditi, Marco Linari, Leonardo Lucii, Pasquale Bianco, Elisabetta Brunello, Valérie Decostre, Alex Stewart, David B. Gore, Thomas C. Irving, Malcolm Irving and Vincenzo Lombardi | | |